Memorial Sloan Kettering Cancer Center Launches Telemedicine Platform

What You Should Know:

– Today, Memorial Sloan Kettering Cancer Center (MSK) announced it has collaborated with Accenture and Microsoft over the last 12 months to help develop and refine MSK Telemedicine. MSK Telemedicine was created to provide patients access to care during the COVID-19 pandemic and into the future, allows MSK patients and families to virtually interact with their entire care team, seamlessly replicating an in-clinic visit.

– With the combined resources of Accenture, Avanade, and Microsoft, MSK’s Digital Informatics & Technology Solutions team developed a standardized telemedicine platform that could be used at scale. MSK Telemedicine integrates with Microsoft Teams, which many clinicians are familiar with, while patients join the meetings via a Web browser experience, eliminating the need to download new software.

How It Works 

Patients receive a secure link to join MSK Telemedicine. They enter the “Virtual Clinic Room” – a virtual space where patients check-in, sign any necessary forms, and complete surveys. MSK care coordinators, nurses, fellows, interpreters, and other clinical team members can join the doctor and patient in the virtual appointment using their existing clinical systems and telemedicine dashboard. Patients and doctors can securely access e-consent forms from within MSK Telemedicine throughout the visit. Additionally, patients can invite family and friends for support through a secure link, allowing for a familiar and effective care experience.